In our quest to understand how RAC3 gene expression correlates with the infiltration of immune cells in BLCA, we categorized the patient data from TCGA database into two groups using the median RAC3 mRNA expression as the dividing criterion. Here, RAC3 is linked to bladder transitional cell carcinoma.